These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 16754630

  • 1. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM, Gimeno JR, Tomé MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ.
    Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
    [Abstract] [Full Text] [Related]

  • 2. Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.
    Efthimiadis GK, Parcharidou DG, Giannakoulas G, Pagourelias ED, Charalampidis P, Savvopoulos G, Ziakas A, Karvounis H, Styliadis IH, Parcharidis GE.
    Am J Cardiol; 2009 Sep 01; 104(5):695-9. PubMed ID: 19699347
    [Abstract] [Full Text] [Related]

  • 3. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR, Tomé-Esteban M, Lofiego C, Hurtado J, Pantazis A, Mist B, Lambiase P, McKenna WJ, Elliott PM.
    Eur Heart J; 2009 Nov 01; 30(21):2599-605. PubMed ID: 19689975
    [Abstract] [Full Text] [Related]

  • 4. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, Schaff HV, Tajik AJ, Gersh BJ.
    Eur Heart J; 2007 Nov 01; 28(21):2583-8. PubMed ID: 17483110
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
    Shah JS, Esteban MT, Thaman R, Sharma R, Mist B, Pantazis A, Ward D, Kohli SK, Page SP, Demetrescu C, Sevdalis E, Keren A, Pellerin D, McKenna WJ, Elliott PM.
    Heart; 2008 Oct 01; 94(10):1288-94. PubMed ID: 18032461
    [Abstract] [Full Text] [Related]

  • 6. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.
    Z Kardiol; 2000 Oct 01; 89 Suppl 3():194-205. PubMed ID: 10810803
    [Abstract] [Full Text] [Related]

  • 7. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ.
    Circ Heart Fail; 2010 Jan 01; 3(1):51-8. PubMed ID: 19850699
    [Abstract] [Full Text] [Related]

  • 8. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.
    Rev Esp Cardiol; 2006 Jun 01; 59(6):537-44. PubMed ID: 16790196
    [Abstract] [Full Text] [Related]

  • 9. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ.
    Eur Heart J; 2007 Jul 01; 28(14):1746-9. PubMed ID: 17283003
    [Abstract] [Full Text] [Related]

  • 10. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 11. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S.
    Am J Cardiol; 2009 Jul 01; 104(1):128-32. PubMed ID: 19576333
    [Abstract] [Full Text] [Related]

  • 12. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.
    Heart; 2009 May 01; 95(9):709-14. PubMed ID: 19282314
    [Abstract] [Full Text] [Related]

  • 13. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F.
    Circulation; 2006 Dec 19; 114(25):2766-72. PubMed ID: 17159063
    [Abstract] [Full Text] [Related]

  • 14. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
    Basso C, Thiene G, Mackey-Bojack S, Frigo AC, Corrado D, Maron BJ.
    Eur Heart J; 2009 Jul 19; 30(13):1627-34. PubMed ID: 19406869
    [Abstract] [Full Text] [Related]

  • 15. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
    Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ.
    N Engl J Med; 2003 Jan 23; 348(4):295-303. PubMed ID: 12540642
    [Abstract] [Full Text] [Related]

  • 16. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M.
    J Card Fail; 2008 Jun 23; 14(5):414-9. PubMed ID: 18514934
    [Abstract] [Full Text] [Related]

  • 17. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy.
    Woo A, Williams WG, Choi R, Wigle ED, Rozenblyum E, Fedwick K, Siu S, Ralph-Edwards A, Rakowski H.
    Circulation; 2005 Apr 26; 111(16):2033-41. PubMed ID: 15824202
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F, ALPHA Study Group Investigators.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1896-904. PubMed ID: 17980258
    [Abstract] [Full Text] [Related]

  • 19. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].
    Maron BJ, Spirito P.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr 06; 37(4):297-302. PubMed ID: 19791462
    [Abstract] [Full Text] [Related]

  • 20. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA.
    Europace; 2009 May 06; 11(5):643-9. PubMed ID: 19164362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.